MedPath

The Effect of Radiofrequency of 448 kHz on Pain and Function

Not Applicable
Completed
Conditions
Chronic Low-back Pain
Lumbago
Low Back Pain, Recurrent
Interventions
Other: Proprioceptive Neuromuscular Facilitation
Device: 448kHz capacitive resistive monopolar radiofrequency
Registration Number
NCT05682287
Lead Sponsor
University of Applied Health Sciences
Brief Summary

The goal of this trial is to compare the effects 448kHz capacitive resistive monopolar radiofrequency (CRM) with Proprioceptive Neuromuscular Facilitation (PNF) versus only PNF in chronic low back pain patients.

The main questions it aims to answer are:

1. Is there any difference in interventions on reduction of pain.

2. Is there any difference in interventions on reduction of disability.

Participants will in the experimental group will be treated with a combination of:

1. 448kHz capacitive resistive monopolar radiofrequency and,

2. PNF intervention

Participants will in the control group will be treated only using

1. PNF intervention (identical to experimental group)

Researchers will compare experimental and control group to see if there are differences in reduction of pain and disability.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • older than 18 years, chronic low back pain (CLBP)
Exclusion Criteria
  • spinal fractures, radiculopathies, history of spinal surgery, spinal stenosis, history of thrombosis, pacemaker, pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupProprioceptive Neuromuscular FacilitationParticipants will exercise for exactly 20 minutes, over the course of two weeks, using the PNF concept exercises to mobilize the pelvis and lumbar spine, primarily strengthening the muscles of the abdomen, back and hips. Therapy will be administered for a total of 5 times in two weeks. Three times in week 1 and two times in week 2. This is identical intervention and the second intervention in the experimental group.
Experimental groupProprioceptive Neuromuscular FacilitationParticipants in the experimental group will be treated with a combination of 448kHz capacitive resistive monopolar radiofrequency and Proprioceptive neuromuscular facilitation (PNF) over the course of two weeks. 1. 448 kHz radio frequency therapy will be carried for a duration of 15 min. Contact cream will be applied beforehand to increase the electrical conductivity in the treated area. 2. After the radiofrequency therapy, participants will exercise for exactly 20 minutes using the PNF concept exercises to mobilize the pelvis and lumbar spine, primarily strengthening the muscles of the abdomen, back and hips. Therapy will be administered for a total of 5 times in two weeks. Three times in week 1 and two times in week 2.
Experimental group448kHz capacitive resistive monopolar radiofrequencyParticipants in the experimental group will be treated with a combination of 448kHz capacitive resistive monopolar radiofrequency and Proprioceptive neuromuscular facilitation (PNF) over the course of two weeks. 1. 448 kHz radio frequency therapy will be carried for a duration of 15 min. Contact cream will be applied beforehand to increase the electrical conductivity in the treated area. 2. After the radiofrequency therapy, participants will exercise for exactly 20 minutes using the PNF concept exercises to mobilize the pelvis and lumbar spine, primarily strengthening the muscles of the abdomen, back and hips. Therapy will be administered for a total of 5 times in two weeks. Three times in week 1 and two times in week 2.
Primary Outcome Measures
NameTimeMethod
Change from baseline: Pain - Visual Analogue Scale (VAS)Change from baseline pain after two weeks (14 days).

Change from baseline pain, measured by 0-10 Visual Analogue Scale (VAS). VAS has a minimum score of 0 and a maximum score of 10. Higher score indicates a worse outcome (e.g., greater pain intensity).

Change from baseline: Disability - ODI (Oswestry Low Back Pain Disability Questionnaire)Change from baseline disability after two weeks (14 days).

Change from baseline disability, measured by Oswestry Low Back Pain Disability Questionnaire. ODI has a minimum score of 0% and maximum score of 100%. Higher score indicates a worse outcome (e.g., greater disability).

Secondary Outcome Measures
NameTimeMethod
Change from baseline: Roland-Morris Disability Questionnaire (RMDQ)Change from baseline disability after two weeks (14 days).

Change from baseline disability, measured by Roland-Morris Disability Questionnaire. RMDQ has a minimum score of 0 and maximum score of 24. Higher score indicates a worse outcome (e.g., greater pain-related disability).

Change from baseline: Disability - Quebec Back Pain Disability Scale (QBPD)Change from baseline disability after two weeks (14 days).

Change from baseline disability, measured by Quebec Back Pain Disability Scale. QBPD has a minimum score of 20 and maximum score of 100. Higher score indicates a worse outcome (e.g., greater disability).

Trial Locations

Locations (1)

Polyclinic Cerebellum

🇭🇷

Varaždin, Varaždinska, Croatia

© Copyright 2025. All Rights Reserved by MedPath